Clinical Trial

COntinuous Glucose Monitoring in nEwborns of Mothers With Insulin-Treated Gestational Diabetes Mellitus

Name: COntinuous Glucose Monitoring in nEwborns of Mothers With Insulin-Treated Gestational Diabetes Mellitus — clinical trial record (NCT07462793)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: COMET-GDM

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine whether continuous glucose monitoring (CGM) improves the detection and management of neonatal hypoglycaemia in newborns of mothers with insulin-treated gestational diabetes.

Trial Details

NCT Number	NCT07462793
Lead Sponsor	Institute of Mother and Child, Warsaw, Poland
Conditions	Neonatal Hypoglycemia, Gestational Diabetes Mellitus (GDM)
Enrollment	120 participants
Start Date	2026-03
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-03-10